HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Dr. Biran, who practices in New Jersey in Hackensack, is actively involved with clinical research focusing on multiple myeloma. She has presented a range of clinical work at international and national conferences such as those of the American Society of Hematology and the Society of Hematologic Oncology. She is widely published in hematology and oncology journals such as American Journal of Hematology, Current Hematologic Malignancy Reports and The Hemophilia Report, with a research focus on high-risk multiple myeloma and the role of minimal residual disease in multiple myeloma. She also has co-authored a chapter in “Essentials of Hospital Medicine: A Practical Guide for Clinicians,” entitled “Oncologic Emergencies.” As a fellow at Icahn School of Medicine, Dr. Biran participated in numerous lecture series and training sessions for medical students, residents and nurse practitioners.
George Washington University, Washington, D.C(Medical Degree)
Ichan School of Medicine at Mount Sinai, N.Y., residency and internship in internal medicine
Icahn School of Medicine at Mount Sinai, N.Y., chief fellow of hematology and medical oncology
European Society for Medical Oncology, American Society of Clinical Oncology , American Society of Hematology
John Theurer Cancer Center, Hackensack, Myeloma Division
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.